Universal Health Services UHS
$179.43 +$4.45 (+2.54%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $179.43 0.00%
Open$176.92
Prev close$174.98
Day range$176.63 – $180.78
Volume908.8K
Market cap$10.34B
P/E (TTM)7.5
Dividend yield0.45%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$4.73B+5.3% YoY
Operating profit$454.45M-12.9% YoY
Net profit$313.33M-17.3% YoY
Diluted EPS$5.22-10.9% YoY
Free cash flow$416.04M+212.6% YoY
Operating cash flow$636.56M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin90.7%
Operating margin10.8%
Net margin8.0%
Return on equity19.8%
Return on assets9.0%
Return on invested capital12.2%
Current ratio1.37
Liabilities / assets55.0%
Cash & investments$168.75M
Total debt$6.10B
Net cash (debt)-$5.93B
Free cash flow / sales6.0%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $4.73B | $4.64B | $4.50B | $17.36B | $4.49B |
| Total Operating Revenue | $4.73B | $4.64B | $4.50B | $17.36B | $4.49B |
| Cost of Revenue | $426.50M | $423.26M | $426.54M | $1.66B | $422.76M |
| Gross Profit | $4.31B | $4.21B | $4.07B | $15.71B | $4.06B |
| Operating Expense | $3.85B | $3.70B | $3.57B | $13.71B | $3.55B |
| Selling and Admin Expenses | $2.25B | $2.18B | $2.13B | $8.23B | $2.09B |
| -General & Admin Expense | $2.25B | $2.18B | $2.13B | $8.23B | $2.09B |
| Depreciation & Amortization & Depletion | $174.85M | $167.34M | $155.43M | $618.74M | $163.33M |
| -Depreciation & Amortization | $174.85M | $167.34M | $155.43M | $618.74M | $163.33M |
| Other Operating Expenses | $1.43B | $1.35B | $1.28B | $4.86B | $1.30B |
| Operating Profit | $454.45M | $516.68M | $502.86M | $1.99B | $517.23M |
| Net Non-Operating Interest Income (Expense) | -$56.28M | -$39.91M | -$37.13M | -$156.07M | -$42.22M |
| Non-Operating Interest Income | $788,000.00 | $102,000.00 | $91,000.00 | $1.19M | $247,000.00 |
| Non-Operating Interest Expense | $55.58M | $38.65M | $35.97M | $152.26M | $41.21M |
| Total Other Finance Costs | $1.49M | $1.36M | $1.25M | $5.00M | $1.25M |
| Other Income (Expense) | $15.74M | $2.36M | $3.39M | $134.19M | $106.43M |
| Other Non-Operating Income (Expenses) | $15.74M | $2.36M | $3.39M | $134.19M | $106.43M |
| Pretax Profit | $413.91M | $479.13M | $469.12M | $1.97B | $581.44M |
| Tax | $100.58M | $114.54M | $110.44M | $460.96M | $133.61M |
| Net Profit | $313.33M | $364.59M | $358.68M | $1.51B | $447.84M |
| Profit from Continuing Operations | $313.33M | $364.59M | $358.68M | $1.51B | $447.84M |
| Minority Interests | $4.65M | $6.14M | $10.00M | $22.39M | $1.90M |
| Net Income to Parent Company | $308.68M | $358.45M | $348.68M | $1.49B | $445.94M |
| Net Income to Common Stockholders | $308.68M | $358.45M | $348.68M | $1.49B | $445.94M |
| Basic EPS | $5.25 | $6.01 | $5.71 | $23.42 | $7.19 |
| Diluted EPS | $5.22 | $5.98 | $5.65 | $23.10 | $7.06 |
| Dividend Per Share | $0.20 | $0.20 | $0.20 | $0.80 | $0.20 |
| Other Preferred Stock Dividends | – | – | – | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $17.19B | $15.94B | $15.68B | $15.53B | $15.53B |
| Total Current Assets | $3.68B | $3.68B | $3.50B | $3.41B | $3.41B |
| Cash and Cash Equivalents & Short-Term Investments | $168.75M | $138.80M | $119.03M | $137.80M | $137.80M |
| -Cash and Cash Equivalents | $168.75M | $138.80M | $119.03M | $137.80M | $137.80M |
| Receivables | $2.81B | $2.80B | $2.75B | $2.60B | $2.60B |
| -Accounts Receivable | $2.81B | $2.80B | $2.75B | $2.60B | $2.60B |
| Inventory | $235.56M | $234.09M | $229.42M | $232.11M | $232.11M |
| Other Current Assets | $462.16M | $505.32M | $406.17M | $435.57M | $435.57M |
| Total Non-Current Assets | $13.51B | $12.26B | $12.18B | $12.12B | $12.12B |
| Net PPE | $7.64B | $7.51B | $7.44B | $7.38B | $7.38B |
| -Gross PPE | $14.47B | $14.20B | $13.99B | $13.86B | $13.86B |
| -Accumulated Depreciation | -$6.83B | -$6.69B | -$6.55B | -$6.48B | -$6.48B |
| Goodwill and Other Intangible Assets | $4.74B | $3.98B | $3.98B | $3.99B | $3.99B |
| -Goodwill | $4.74B | $3.98B | $3.98B | $3.99B | $3.99B |
| Non-Current Deferred Assets | $105.21M | $73.63M | $77.57M | $79.79M | $79.79M |
| Other Non-Current Assets | $1.02B | $692.44M | $684.25M | $667.34M | $667.34M |
| Total Liabilities | $9.44B | $8.28B | $8.08B | $8.12B | $8.12B |
| Total Current Liabilities | $2.69B | $3.30B | $3.24B | $3.24B | $3.24B |
| Payables | $2.53B | $2.45B | $2.41B | $1.02B | $1.02B |
| -Accounts Payable | $2.52B | $2.45B | $2.36B | $750.13M | $750.13M |
| -Total Tax Payable | $6.27M | $3.70M | $58.59M | $269.83M | $269.83M |
| Short-Term Debt and Capital Lease Obligation | $159.64M | $842.77M | $829.14M | $821.40M | $821.40M |
| -Current Debt | $79.81M | $771.91M | $756.24M | $748.16M | $748.16M |
| -Current Capital Lease Obligation | $79.82M | $70.86M | $72.90M | $73.24M | $73.24M |
| Total Non-Current Liabilities | $6.76B | $4.98B | $4.83B | $4.88B | $4.88B |
| Long Term Debt and Capital Lease Obligation | $6.02B | $4.42B | $4.30B | $4.35B | $4.35B |
| -Long Term Debt | $5.63B | $4.08B | $3.95B | $4.00B | $4.00B |
| -Long Term Capital Lease Obligation | $389.15M | $339.47M | $344.56M | $340.72M | $340.72M |
| Non-Current Deferred Liabilities | $3.23M | $3.23M | $3.23M | $5.65M | $5.65M |
| Other Non-Current Liabilities | $736.43M | $559.96M | $532.68M | $527.83M | $527.83M |
| Total Equity | $7.74B | $7.66B | $7.60B | $7.41B | $7.41B |
| Stockholders' Equity | $7.60B | $7.51B | $7.46B | $7.28B | $7.28B |
| Capital Stock | $577,000.00 | $590,000.00 | $608,000.00 | $611,000.00 | $611,000.00 |
| -Common Stock | $577,000.00 | $590,000.00 | $608,000.00 | $611,000.00 | $611,000.00 |
| Retained Earnings | $8.36B | $8.26B | $8.20B | $7.99B | $7.99B |
| Gains/Losses Not Affecting Retained Earnings | $42.06M | $38.26M | $39.08M | $47.78M | $47.78M |
| Other Equity Interests | -$801.86M | -$789.82M | -$777.91M | -$765.36M | -$765.36M |
| Minority Interests | $145.22M | $141.43M | $139.62M | $133.62M | $133.62M |
| Current Accrued Expenses | – | – | – | $716.66M | $716.66M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $636.56M | $443.30M | $401.63M | $1.86B | $574.69M |
| Net cash flow from continuing operations | $636.56M | $443.30M | $401.63M | $1.86B | $574.69M |
| Net Income from Continuing Operations | $313.33M | $364.59M | $358.68M | $1.51B | $447.84M |
| Gain/Loss from Continuing Operations | -$737,000.00 | -$532,000.00 | -$5.05M | -$85.32M | -$88.16M |
| Depreciation & Depletion & Amortization | $174.85M | $167.34M | $155.43M | $618.74M | $163.33M |
| Other Non-Cash Items | -$52.47M | -$51.32M | -$49.02M | -$259.48M | -$96.50M |
| Change in Working Capital | $175.22M | -$59.68M | -$80.92M | -$16.42M | $123.07M |
| -Change in Receivables | $21.47M | -$14.05M | -$123.86M | -$317.99M | -$23.78M |
| -Change in Payables and Accrued Expense | $126.08M | $8.83M | $178.33M | $211.28M | $66.46M |
| -Change in Other Current Assets | $7.16M | -$6.21M | -$12.26M | -$28.60M | $1.03M |
| -Change In Other Working Capital | $20.51M | -$48.26M | -$123.13M | $118.89M | $79.36M |
| Net cash flow from investing | -$1.21B | -$234.23M | -$197.58M | -$1.07B | -$223.97M |
| Net Cash Flow from Continuing Investing Activities | -$1.21B | -$234.23M | -$197.58M | -$1.07B | -$223.97M |
| Net PPE Purchase and Sale | -$220.51M | -$232.98M | -$221.77M | -$1.04B | -$287.24M |
| Net Business Purchase and Sale | -$997.91M | -$28,000.00 | -$4.83M | -$47.66M | $10,000.00 |
| Net Investment Purchase and Sale | $4.21M | -$2.71M | $14.72M | $1.03M | $50.38M |
| Net Other Investing Changes | $2.10M | $1.48M | $14.30M | $15.86M | $12.88M |
| Financing Cash Flow | $605.73M | -$189.49M | -$221.89M | -$749.73M | -$296.14M |
| Net Cash Flow from Continuing Financing Activities | $605.73M | -$189.49M | -$221.89M | -$749.73M | -$296.14M |
| Net Issuance Payments Of Debt | $873.26M | $142.99M | -$44.69M | $242.03M | $60.84M |
| Net Common Stock Issuance | -$240.99M | -$315.88M | -$160.07M | -$951.22M | -$347.40M |
| Cash Dividends Paid | -$11.79M | -$11.79M | -$12.97M | -$51.27M | -$12.37M |
| Net Other Financing Charges | -$14.75M | -$4.81M | -$4.16M | $10.73M | $2.79M |
| Ending Cash Balance | $302.58M | $272.38M | $252.55M | $271.32M | $271.32M |
| Net Change in Cash | $30.16M | $19.58M | -$17.85M | $44.05M | $54.59M |
| Beginning Cash Balance | $272.38M | $252.55M | $271.32M | $224.75M | $216.60M |
| Effect of Exchange Rate Changes | $37,000.00 | $248,000.00 | -$924,000.00 | $2.52M | $127,000.00 |
| Free Cash Flow | $416.04M | $210.32M | $179.86M | $824.55M | $287.45M |
No comments yet — be the first to weigh in on UHS.
Sign in to join the discussion.